Tinavi Medical Technologies Hits Day Low of CNY 16.50 Amid Price Pressure

Tinavi Medical Technologies Co., Ltd. experienced significant volatility on July 13, 2026, with the stock declining by 10.09% and reaching an intraday low of CNY 16.50. This performance starkly contrasts with the China Shanghai Composite, which fell by only 2.06% on the same day. Over the past week, Tinavi's stock has dropped 8.8%, while its monthly performance reflects a decrease of 5.26%. Despite a year-to-date gain of 9.15%, the company has faced challenges, including a 35.23% decline over the past five years. The company's financial metrics reveal a concerning picture, with a return on capital employed (ROCE) of 0% and a negative net worth, indicating potential difficulties in sustaining operations without raising new capital or achieving profitability. Tinavi's recent quarterly results showed an operating profit of CNY -55.61 million, marking the lowest point for the company, with an operating profit margin of -89.45%. These figures highlight ongoing financial struggles within the mid-cap pharmaceuticals and biotechnology sector, where Tinavi operates.